BBB022A

a type IV phosphodiesterase inhibitor that protects against blood-brain barrier disruption in focal cerebral ischemia; no other information available 7/1999

Also Known As:

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/01/1999 - "Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors."

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Rolipram
3.	Phosphodiesterase Inhibitors